Lake Street Maintains Buy on Cellebrite DI, Lowers Price Target to $22
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Lake Street analyst Eric Martinuzzi maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $24 to $22.
Lake Street analyst Eric Martinuzzi maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $24 to $22.